Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis

Código QR

Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis

Abstract Data regarding genetic polymorphisms and platinum-based chemotherapy (PBC) treatment outcomes in patients with NSCLC are published at a growing pace, but the results are inconsistent. This meta-analysis integrated eligible candidate genes to better evaluate the pharmacogenetics of PBC in NS...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Li-Ming Tan, Cheng-Feng Qiu, Tao Zhu, Yuan-Xiang Jin, Xi Li, Ji-Ye Yin, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/35e6063d82c348a08514b744c15b0e47
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The influence of genetic polymorphisms on the toxicity of platinum-based chemotherapy in the treatment of non-small cell lung cancer
por: Spasić Jelena, et al.
Publicado: (2021)

Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma
por: Xiaoyu Zhai, et al.
Publicado: (2017)

Gene-gene and gene-environment interactions influence platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients
por: Jia-Jia Cui, et al.
Publicado: (2017)

Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
por: Katrina Kildey, et al.
Publicado: (2021)

Predictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients
por: Huan Ye, et al.
Publicado: (2017)

Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer
por: Laura Elena Pineda Lancheros, et al.
Publicado: (2021)

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
por: Du Y, et al.
Publicado: (2018)

Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy
por: Hui-Shan Huang, et al.
Publicado: (2018)

Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small‐cell lung cancer patients treated with first‐line platinum‐containing chemotherapy
por: Man He, et al.
Publicado: (2021)

The shared genetic architecture between epidemiological and behavioral traits with lung cancer
por: Rowland W. Pettit, et al.
Publicado: (2021)

Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy.
por: Margot Geens, et al.
Publicado: (2021)

First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis
por: Youwen Zhu, et al.
Publicado: (2021)

Correlation between MTHFR 677C > T polymorphism and response of pemetrexed-based chemotherapy in advanced NSCLC: A meta-analysis
por: Han Feng, et al.
Publicado: (2021)

Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)
por: Tsuchiya-Kawano Y, et al.
Publicado: (2021)

S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.
por: Ming-ming He, et al.
Publicado: (2013)

Genetic sensitivity analysis: Adjusting for genetic confounding in epidemiological associations.
por: Jean-Baptiste Pingault, et al.
Publicado: (2021)

Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
por: Kanyarat Khaeso, et al.
Publicado: (2021)

Development of an ultra-dense genetic map of the sunflower genome based on single-feature polymorphisms.
por: John E Bowers, et al.
Publicado: (2012)

Genetic polymorphisms as prognostic factors for recurrent kidney stones: A systematic review and meta-analysis.
por: Widi Atmoko, et al.
Publicado: (2021)

CYTOKINES GENETIC POLYMORPHISM: THE PAST AND THE FUTURE
por: L. V. Puzyryova, et al.
Publicado: (2016)

Genetic polymorphisms and sepsis in premature neonates.
por: Susanna Esposito, et al.
Publicado: (2014)

Lung cancer susceptibility model based on age, family history and genetic variants.
por: Robert P Young, et al.
Publicado: (2009)

Genetic diversity of strawberry cultivars in Banyuroto, Magelang, Indonesia based on Cleaved Amplified Polymorphic Sequence
por: MUHAMMAD FAUZI ARIF, et al.
Publicado: (2019)

Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer.
por: Qiao Liu, et al.
Publicado: (2021)

Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer
por: Qiao Liu, et al.
Publicado: (2021)

Disease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice
por: Mencinger Marina, et al.
Publicado: (2021)

MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients
por: Purwanto I, et al.
Publicado: (2021)

Genetic contribution of CISH promoter polymorphisms to susceptibility to tuberculosis in Chinese children.
por: Lin Sun, et al.
Publicado: (2014)

Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer
por: Minami S, et al.
Publicado: (2016)

Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies
por: Junjun Wang, et al.
Publicado: (2017)

Assessment of genetic diversity and variety identification based on developed retrotransposon-based insertion polymorphism (RBIP) markers in sweet potato (Ipomoea batatas (L.) Lam.)
por: Yusha Meng, et al.
Publicado: (2021)

Genetic diversity of Sterculia quadrifida in Kupang, Indonesia based on RAPD (Random Amplified Polymorphic DNA) markers
por: Uslan Uslan, et al.
Publicado: (2020)

Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity.
por: Jennifer L Taylor-Cousar, et al.
Publicado: (2009)

Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience
por: Vrankar Martina, et al.
Publicado: (2021)

Environmental and genetic contribution to hypertension prevalence: data from an epidemiological survey on Sardinian genetic isolates.
por: Ginevra Biino, et al.
Publicado: (2013)

Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
por: Rong Liu, et al.
Publicado: (2017)

Genetic characteristics and epidemiology of inherited retinal degeneration in Taiwan
por: Ta-Ching Chen, et al.
Publicado: (2021)

Genetic and Genomic Epidemiology of Stroke in People of African Ancestry
por: Savvina Prapiadou, et al.
Publicado: (2021)

Genetic epidemiology of tuberculosis susceptibility: impact of study design.
por: Catherine M Stein
Publicado: (2011)

Molecular genetic portrait of non-small cell lung cancer in Tambov region: regional experience
por: N. A. Ognerubov, et al.
Publicado: (2020)